Teleflex stock holds firm after August 6 beat

Teleflex stock is steady after the company topped second-quarter EPS by $0.48 and revenue by $10.74 million on August 6, 2026.

Teleflex Inc. (US8793691069) closed a second-quarter update on August 6, 2026 with earnings of $1.76 a share and revenue of $570.33 million, both above estimates. Shares opened at $137.65 on August 28, 2026, while the company carried a market value of $5.83 billion.

Second-quarter numbers

The report showed consensus EPS at $1.28 and revenue estimates at $559.59 million, so the quarter came in ahead on both lines. That leaves a quantified gap of $0.48 a share and $10.74 million in sales, which is the clearest fresh comparison in the current tape.

The same update also keeps the focus on margin pressure and valuation. Teleflex traded at a price-to-earnings ratio of -5.91 and a price-to-earnings-growth ratio of 0.92 in the same market snapshot.

Market setup

The stock's 52-week range is $100.18 to $145.00, with a 50-day moving average of $133.60 and a 200-day moving average of $125.81. On that scale, the August 28 open sat above both moving averages and below the one-year high.

Institutional ownership stood at 95.62 percent in the same market snapshot. The setup keeps the stock tied to execution and to how investors read the next leg of operating results.

About Teleflex

Teleflex is a diversified medical technology company with a focus on critical care and surgery. Its product set includes devices used in hospital procedures, where revenue tends to track procedure volumes and hospital demand.

Shares and valuation

Teleflex stock opened at $137.65 on August 28, 2026, with a market capitalization of $5.83 billion and a one-year high of $145.00. The shares trade in range, but the August 6 beat gives the name a concrete earnings anchor heading into the next reporting date.

Fact box

Company: Teleflex Inc.
ISIN: US8793691069
Ticker: TFX
Exchange: NYSE
Price (as of August 28, 2026): $137.65 USD
Market cap: $5.83 billion
Sector / Industry: Health Care / Medical Devices
Index membership: S&P 500